Related Experiment Video
Updated: Dec 12, 2025

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
MiR-23a induced the activation of CDC42/PAK1 pathway and cell cycle arrest in human cov434 cells by targeting FGD4
Ji Lin1,2,3, Huijuan Huang2, Liheng Lin4
1Graduate School, Fujian Medical University, Fuzhou, China.
Background:
MiRNAs play important roles in the development of ovarian cancer, activation of primitive follicles, follicular development, oocyte maturation and ovulation. In the present study, we investigated the specific role of miR-23a in cov434 cells.
Results:
Downregulation of miR-23a was observed in serum of PCOS patients compared with the healthy control, suggesting the inhibitory effect of miR-23a in PCOS. MiR-23a was positively correlated with Body Mass Index (BMI) and negatively correlated with Luteinizing hormone (LH), Testostrone (T), Glucose (Glu) and Insulin (INS) of PCOS patients. MiR-23a mimic inhibited the proliferation and promoted apoptosis of human cov434 cells. In addition, flow cytometry assay confirmed that miR-23a blocked cell cycle on G0/G1 phase. MiR-23a inhibitor showed opposite results. Furthermore, double luciferase reporter assay proved that miR-23a could bind to the 3'UTR of FGD4 directly through sites predicted on Target Scan. FGD4 level was significantly suppressed by miR-23a mimic, but was significantly enhanced by miR-23a inhibitor. We further proved that miR-23a increased the expression of activated CDC42 (GTP bround) and p-PAK-1, suggesting that miR-23a induced cell cycle arrest through CDC42/PAK1 pathway.
Conclusions:
In conclusion, our study reveals that miR-23a participates in the regulation of proliferation and apoptosis of cov434 cells through target FGD4, and may play a role in the pathophysiology of PCOS.
Insights
MicroRNA-23a (miR-23a) downregulation is linked to Polycystic Ovary Syndrome (PCOS). MiR-23a regulates cell proliferation and apoptosis via FGD4, impacting PCOS pathophysiology.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are crucial in ovarian function, including follicular development and ovulation.
- Dysregulation of miRNAs is implicated in ovarian cancer and polycystic ovary syndrome (PCOS).
Purpose of the Study:
- To investigate the specific role of microRNA-23a (miR-23a) in human granulosa-like cells (cov434).
- To explore the potential involvement of miR-23a in the pathophysiology of PCOS.
Main Methods:
- Analysis of miR-23a levels in PCOS patients' serum.
- In vitro studies using miR-23a mimic and inhibitor in cov434 cells.
- Cell proliferation assays, apoptosis assays, flow cytometry for cell cycle analysis.
- Double luciferase reporter assay to confirm direct targeting of FGD4.
- Western blotting to assess CDC42 and PAK1 activation.
Main Results:
- Serum miR-23a was downregulated in PCOS patients and correlated with BMI, LH, Testosterone, Glucose, and Insulin.
- miR-23a mimic inhibited cov434 cell proliferation and induced apoptosis, arresting the cell cycle at G0/G1 phase.
- miR-23a directly targets FGD4, suppressing its expression.
- miR-23a activation of CDC42/PAK1 pathway mediates cell cycle arrest.
Conclusions:
- miR-23a regulates proliferation and apoptosis in cov434 cells by targeting FGD4.
- miR-23a plays a significant role in the pathophysiology of PCOS.
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Positive Regulator Molecules
Abnormal Proliferation
Mitogens and the Cell Cycle

